title: [Delirium in the elderly].
abstract: Delirium occurs in 20 - 50 % of hospitalized elderly patients. An age > 65 years is one of the factors predisposing to the development of delirium, which is a common syndrome in geriatric medicine. Two clinical guidelines on this condition were published in 2010: NICE clinical guideline 103, "Delirium: diagnosis, prevention, management" and the German guideline "S3-Leitlinie Analgesie, Sedierung und Delirmanagement in der Intensivmedizin". The article gives an overview of new aspects of delirium in the clinical context.
authors: Medizinische Klinik 2, Geriatrie, Klinikum Nürnberg. katrin.singler@klinikum-nuernberg.de
authors: K
authors: K
authors: Singler
authors: B
authors: B
authors: Singler
authors: H J
authors: HJ
authors: Heppner
mesh_terms: D000368:Aged; D000701:Analgesics, Opioid / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D003693:Delirium / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control / Q000628:therapy; D004359:Drug Therapy, Combination; D005858:Germany; D006760:Hospitalization; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects / Q000627:therapeutic use; D007362:Intensive Care Units; D048448:Phenylcarbamates / Q000009:adverse effects / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D000068836:Rivastigmine
chemical_list: D000701:Analgesics, Opioid; D014150:Antipsychotic Agents; D002800:Cholinesterase Inhibitors; D006993:Hypnotics and Sedatives; D048448:Phenylcarbamates; D000068836:Rivastigmine